文献速递前列腺增生与排尿功能障碍男科与性医学

多学科慢性盆腔疼痛研究方法网络中泌尿科慢性盆腔疼痛综合征发作的纵向分析

A longitudinal analysis of urological chronic pelvic pain syndrome flares in the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.
PubMed 文献 · BJU Int · 2019-05-29

基于多学科慢性盆腔疼痛研究方法(MAPP)流行病学与表型纵向研究,每两周评估385名合格参与者的发作状态。24.2%无发作,24.6%报告≥4次发作,11个月随访期间最多18次。发作期间盆腔疼痛平均加重2.63分、泌尿症状平均加重1.72分,女性及非发作期症状更重、膀胱高敏感、慢性重叠疼痛状况者发作更常见、症状更重或持续时间更长。

要点

  • 385名参与者中24.2%无发作,24.6%报告≥4次发作,11个月内最多18次。
  • 多数发作期间盆腔疼痛平均加重2.63分、泌尿症状平均加重1.72分。
  • 女性及非发作期症状更重、膀胱高敏感、慢性重叠疼痛状况者发作更常见、更重或更长。

核心结论

  • 盆腔疼痛和泌尿症状发作常见,但频率和表现变异大。
  • 识别出发作更频繁、症状更重或持续时间更长的参与者亚组,可用于针对性发作管理/预防和进一步研究。

研究设计与样本

  • 多学科慢性盆腔疼痛研究方法(MAPP)流行病学与表型纵向研究。
  • 每两周评估一次当前发作状态(泌尿或盆腔疼痛症状比平时严重得多)。
  • 评估参与者前三次发作及三次随机选择的非发作时间的发作特征,包括开始日期和当前盆腔疼痛、尿急、尿频强度(0-10分量表)。
  • 使用广义线性模型和混合效应模型研究发作风险因素。
  • 385名合格参与者,随访11个月。

主要发现

  • 385名合格参与者中,24.2%无发作,22.9%报告1次发作,28.3%报告2-3次发作,24.6%报告≥4次发作,11个月随访期间最多18次。
  • 中位发生率=0.13/每两周评估,范围=0.00-1.00。
  • 多数发作(60.6%)期间盆腔疼痛(平均增加2.63分)和泌尿症状(平均增加1.72分)均显著加重,参与者内变异性为26.2-37.8%。
  • 发作持续时间从1天到150天不等(参与者内变异性94.3%)。
  • 调整分析中,女性和非发作期症状更重、膀胱高敏感、慢性重叠疼痛状况者发作更常见、症状更重和/或持续时间更长。

临床怎么用

  • 作者认为,识别出的发作更频繁、症状更重或持续时间更长的参与者亚组可用于针对性发作管理/预防和进一步研究。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the frequency, intensity and duration of urological chronic pelvic pain syndrome symptom exacerbations ('flares'), as well as risk factors for these features, in the Multidisciplinary Approach to the Study of Chronic Pelvic Pain Epidemiology and Phenotyping longitudinal study. PARTICIPANTS AND METHODS: Current flare status ('urological or pelvic pain symptoms that are much worse than usual') was ascertained at each bi-weekly assessment. Flare characteristics, including start date, and current intensity of pelvic pain, urgency and frequency (scales of 0-10), were assessed for participants' first three flares and at three randomly selected times when they did not report a flare. Generalized linear and mixed effects models were used to investigate flare risk factors. RESULTS: Of the 385 eligible participants, 24.2% reported no flares, 22.9% reported one flare, 28.3% reported 2-3 flares, and 24.6% reported ≥4 flares, up to a maximum of 18 during the 11-month follow-up (median incidence rate = 0.13/bi-weekly assessment, range = 0.00-1.00). Pelvic pain (mean = 2.63-point increase) and urological symptoms (mean = 1.72) were both significantly worse during most flares (60.6%), with considerable within-participant variability (26.2-37.8%). Flare duration varied from 1 to 150 days (94.3% within-participant variability). In adjusted analyses, flares were more common, symptomatic, and/or longer-lasting in women and in those with worse non-flare symptoms, bladder hypersensitivity, and chronic overlapping pain conditions. CONCLUSION: In this foundational flare study, we found that pelvic pain and urological symptom flares were common, but variable in frequency and manifestation. We also identified subgroups of participants with more frequent, symptomatic, and/or longer-lasting flares for targeted flare management/prevention and further study.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Sutcliffe S, Gallop R, Henry Lai HH, et al. A longitudinal analysis of urological chronic pelvic pain syndrome flares in the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network. BJU Int. 2019. PMID: 31012513. doi:10.1111/bju.14783

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。